Abstract # 2609 Bexxar Protocol CP98-020: Results with I-131 Labeled Antibody in Patients with Non-Hodgkins Lymphoma Refractory to Chemotherapy and Rituxan

Presenter: Quick, Donald

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

Contact the presenter at: rmark@covhs.org

D. Quick*1, R. J. Mark*1,2, P. J. Anderson*1, T. R. Neumann*1, R. S. Akins*3, M. Nair*1. , 1Joe Arrington Cancer Center, Lubbock, TX, 2Texas Tech University, Lubbock, TX, 3University of Miami, Miami, FL,

Author Disclosure:
D. Quick, None;R.J. Mark, None;P.J. Anderson, None;T.R. Neumann, None;R.S. Akins, None;M. Nair, None.

E-mail a friend about this abstract:
Enter email address: